skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Hepatitis C remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Fast Identification of Possible Drug Treatment of Coronavirus Disease-19 (COVID-19) through Computational Drug Repurposing Study
Fast Identification of Possible Drug Treatment of Coronavirus Disease-19 (COVID-19) through Computational Drug Repurposing Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Fast Identification of Possible Drug Treatment of Coronavirus Disease-19 (COVID-19) through Computational Drug Repurposing Study

Wang, Junmei

Journal of chemical information and modeling, 2020-06, Vol.60 (6), p.3277-3286 [Periódico revisado por pares]

United States: American Chemical Society

Texto completo disponível

Citações Citado por
2
A two-pronged strategy to suppress host protein synthesis by SARS coronavirus Nsp1 protein
A two-pronged strategy to suppress host protein synthesis by SARS coronavirus Nsp1 protein
Material Type:
Artigo 		Adicionar ao Meu Espaço

A two-pronged strategy to suppress host protein synthesis by SARS coronavirus Nsp1 protein

Kamitani, Wataru ; Huang, Cheng ; Narayanan, Krishna ; Lokugamage, Kumari G ; Makino, Shinji

Nature structural & molecular biology, 2009-11, Vol.16 (11), p.1134-1140 [Periódico revisado por pares]

United States: Nature Publishing Group

Texto completo disponível

Citações Citado por
3
Anti-HCV and anti-malaria agent, potential candidates to repurpose for coronavirus infection: Virtual screening, molecular docking, and molecular dynamics simulation study
Anti-HCV and anti-malaria agent, potential candidates to repurpose for coronavirus infection: Virtual screening, molecular docking, and molecular dynamics simulation study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Anti-HCV and anti-malaria agent, potential candidates to repurpose for coronavirus infection: Virtual screening, molecular docking, and molecular dynamics simulation study

Hosseini, Faezeh Sadat ; Amanlou, Massoud

Life sciences (1973), 2020-10, Vol.258, p.118205-118205, Article 118205 [Periódico revisado por pares]

Netherlands: Elsevier Inc

Texto completo disponível

Citações Citado por
4
Global prevalence of pre-existing HCV variants resistant to direct-acting antiviral agents (DAAs): mining the GenBank HCV genome data
Global prevalence of pre-existing HCV variants resistant to direct-acting antiviral agents (DAAs): mining the GenBank HCV genome data
Material Type:
Artigo 		Adicionar ao Meu Espaço

Global prevalence of pre-existing HCV variants resistant to direct-acting antiviral agents (DAAs): mining the GenBank HCV genome data

Chen, Zhi-Wei ; Li, Hu ; Ren, Hong ; Hu, Peng

Scientific reports, 2016-02, Vol.6 (1), p.20310-20310, Article 20310 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
5
Molecular dynamics and docking reveal the potency of novel GTP derivatives against RNA dependent RNA polymerase of genotype 4a HCV
Molecular dynamics and docking reveal the potency of novel GTP derivatives against RNA dependent RNA polymerase of genotype 4a HCV
Material Type:
Artigo 		Adicionar ao Meu Espaço

Molecular dynamics and docking reveal the potency of novel GTP derivatives against RNA dependent RNA polymerase of genotype 4a HCV

Elfiky, Abdo A. ; Ismail, Alaa

Life sciences (1973), 2019-12, Vol.238, p.116958-116958, Article 116958 [Periódico revisado por pares]

Netherlands: Elsevier Inc

Texto completo disponível

Citações Citado por
6
Drug resistance against HCV NS3/4A inhibitors is defined by the balance of substrate recognition versus inhibitor binding
Drug resistance against HCV NS3/4A inhibitors is defined by the balance of substrate recognition versus inhibitor binding
Material Type:
Artigo 		Adicionar ao Meu Espaço

Drug resistance against HCV NS3/4A inhibitors is defined by the balance of substrate recognition versus inhibitor binding

Romano, Keith P. ; Ali, Akbar ; Royer, William E. ; Schiffer, Celia A. ; Coffin, John M.

Proceedings of the National Academy of Sciences - PNAS, 2010-12, Vol.107 (49), p.20986-20991 [Periódico revisado por pares]

United States: National Academy of Sciences

Texto completo disponível

Citações Citado por
7
The Role of RASs /RVs in the Current Management of HCV
The Role of RASs /RVs in the Current Management of HCV
Material Type:
Artigo 		Adicionar ao Meu Espaço

The Role of RASs /RVs in the Current Management of HCV

Malandris, Konstantinos ; Kalopitas, Georgios ; Theocharidou, Eleni ; Germanidis, Georgios

Viruses, 2021-10, Vol.13 (10), p.2096 [Periódico revisado por pares]

Switzerland: MDPI AG

Texto completo disponível

Citações Citado por
8
In Vitro Resistance Profile of the Hepatitis C Virus NS3/4A Protease Inhibitor TMC435
In Vitro Resistance Profile of the Hepatitis C Virus NS3/4A Protease Inhibitor TMC435
Material Type:
Artigo 		Adicionar ao Meu Espaço

In Vitro Resistance Profile of the Hepatitis C Virus NS3/4A Protease Inhibitor TMC435

LENZ, Oliver ; VERBINNEN, Thierry ; VERMEIREN, Katrien ; IVENS, Tania ; RABOISSON, Pierre ; EDLUND, Michael ; STORM, Susan ; VRANG, Lotta ; DE KOCK, Herman ; FANNING, Gregory C ; SIMMEN, Kenneth A ; LIN, Tse-I ; VIJGEN, Leen ; CUMMINGS, Maxwell D ; LINDBERG, Jimmy ; MARTIN BERKE, Jan ; DEHERTOGH, Pascale ; FRANSEN, Els ; SCHOLLIERS, Annick

Antimicrobial Agents and Chemotherapy, 2010-05, Vol.54 (5), p.1878-1887 [Periódico revisado por pares]

Washington, DC: American Society for Microbiology

Texto completo disponível

Citações Citado por
9
Discovery of MK-8742: An HCV NS5A Inhibitor with Broad Genotype Activity
Discovery of MK-8742: An HCV NS5A Inhibitor with Broad Genotype Activity
Material Type:
Artigo 		Adicionar ao Meu Espaço

Discovery of MK-8742: An HCV NS5A Inhibitor with Broad Genotype Activity

Coburn, Craig A. ; Meinke, Peter T. ; Chang, Wei ; Fandozzi, Christine M. ; Graham, Donald J. ; Hu, Bin ; Huang, Qian ; Kargman, Stacia ; Kozlowski, Joseph ; Liu, Rong ; McCauley, John A. ; Nomeir, Amin A. ; Soll, Richard M. ; Vacca, Joseph P. ; Wang, Dahai ; Wu, Hao ; Zhong, Bin ; Olsen, David B. ; Ludmerer, Steven W.

ChemMedChem, 2013-12, Vol.8 (12), p.1930-1940 [Periódico revisado por pares]

Weinheim: WILEY-VCH Verlag

Texto completo disponível

Citações Citado por
10
A short hepatitis C virus NS5A peptide expression by AAV vector modulates human T cell activation and reduces vector immunogenicity
A short hepatitis C virus NS5A peptide expression by AAV vector modulates human T cell activation and reduces vector immunogenicity
Material Type:
Artigo 		Adicionar ao Meu Espaço

A short hepatitis C virus NS5A peptide expression by AAV vector modulates human T cell activation and reduces vector immunogenicity

Colon-Moran, Winston ; Baer, Alan ; Lamture, Gauri ; Stapleton, Jack T ; Fischer, Joseph W ; Bhattarai, Nirjal

Gene therapy, 2022-11, Vol.29 (10-11), p.616-623 [Periódico revisado por pares]

England: Nature Publishing Group

Sem texto completo

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (932)
  2. Revistas revisadas por pares (948)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (969)
  2. Dissertações  (1)
  3. Book Chapters  (1)
  4. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1996  (18)
  2. 1996Até2002  (47)
  3. 2003Até2009  (145)
  4. 2010Até2017  (519)
  5. Após 2017  (243)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (969)
  2. Japonês  (189)
  3. Alemão  (4)
  4. Português  (3)
  5. Chinês  (3)
  6. Russo  (1)
  7. Espanhol  (1)
  8. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.